Wollenberg A, Howell MD, Guttman-Yassky E, Silverberg JI, Birrell C, Kell C, Ranade K, Dawson M, van der Merwe R. A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis. J of Skin [Internet]. 2018Feb.23 [cited 2024Jul.22];2(S1):S29. Available from: https://jofskin.org/index.php/skin/article/view/281